|
2025
|
Invention
|
Combination therapy with an anti-colony stimulating factor 1 receptor antibody and a jak inhibito... |
|
2024
|
Invention
|
Method of treating cancer using a combination of entinostat and an anti-csf-1r antibody.
The pre... |
|
|
Invention
|
Salts and polymorphic forms of menin inhibitors and pharmaceutical compositions thereof.
The pre... |
|
|
Invention
|
Salts and polymorphic forms of revumenib. The present disclosure relates to a novel salt and salt... |
|
|
Invention
|
Aryl ether analogs as inhibitors of the menin-mll interaction. The present disclosure is directed... |
|
|
Invention
|
Combination of hdac inhibitor and anti-pd-1 antibody for treatment of cancer.
Described herein a... |
|
|
Invention
|
Methods of treating chronic graft-versus-host disease-related bronchiolitis obliterans syndrome u... |
|
|
Invention
|
Selection of patients for combination therapy.
Described herein are methods for selecting cancer... |
|
|
P/S
|
Providing financial assistance programs to qualified patients who have a demonstrated financial n... |
|
2023
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. Research and development of pharmaceutic... |
|
|
Invention
|
Menin-mll inhibitors for the treatment of cancer.
The present disclosure is directed to methods ... |
|
|
Invention
|
Menin-mll inhibitors for the treatment of cancer. The present disclosure is directed to methods o... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer Research and development of pharmaceutica... |
|
|
P/S
|
Research and development of pharmaceuticals for the treatment of cancer; medical and scientific r... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2022
|
Invention
|
Inhibitors of the menin-mll interaction.
The present disclosure is directed to inhibitors of For... |
|
|
Invention
|
Inhibitors of the menin-mll interaction. The present disclosure is directed to inhibitors of Form... |
|
|
Invention
|
Combinations for treatment of cancer.
The present disclosure is directed to combinations of meni... |
|
|
Invention
|
Combinations for treatment of cancer. The present disclosure is directed to combinations of menin... |
|
2021
|
Invention
|
Combinations of menin inhibitors and cyp3a4 inhibitors and methods of use thereof.
The present i... |
|
|
Invention
|
Combinations of menin inhibitors and cyp3a4 inhibitors and methods of use thereof. The present in... |
|
2020
|
Invention
|
Antibodies for the treatment of chronic graft versus host disease.
The present invention relates... |
|
|
Invention
|
Antibodies for the treatment of chronic graft versus host disease. The present invention relates ... |
|
2019
|
Invention
|
Selection of patients for combination therapy. Described herein are methods for selecting cancer ... |
|
|
Invention
|
Methods for the treatment of breast cancer.
Described herein are methods for the treatment of br... |
|
2018
|
Invention
|
Method of treating cancer using a combination of entinostat and an anti-csf-1r antibody. The pres... |
|
|
Invention
|
Combination therapies. The present disclosure relates to a combination of an anti-CSF-1R antibody... |
|
|
Invention
|
Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy. The present di... |
|
2016
|
Invention
|
Combination of hdac inhibitor and anti-pd-l1 antibody for treatment of ovarian cancer.
Described... |
|
|
Invention
|
Combination of hdac inhibitor and anti-pd-l1 antibody for treatment of ovarian cancer. Described ... |
|
|
Invention
|
Combination of hdac inhibitor and anti-pd-l1 antibody for treatment of cancer.
Described herein ... |
|
|
Invention
|
Combination of hdac inhibitor and anti-pd-l1 antibody for treatment of cancer. Described herein a... |
|
|
Invention
|
Combination of hdac inhibitor and anti-pd-1 antibody for treatment of cancer. Described herein ar... |
|
|
P/S
|
pharmaceutical preparations for the treatment of cancer research and development of pharmaceutica... |
|
2014
|
Invention
|
Methods for the treatment of cancer. Described herein are methods for the treatment of cancer in ... |
|
2013
|
Invention
|
Administration of an inhibitor of hdac.
Methods of treating patients with SNDX-275 are provided. |
|
2012
|
Invention
|
Methods for the treatment of lung cancer.
Described herein are methods for the treatment of lung... |
|
|
Invention
|
Methods for the treatment of breast cancer. Described herein are methods for the treatment of bre... |
|
|
Invention
|
Prodrugs of azacitidine 5' -diphosphate. The present disclosure relates to analogs or derivatives... |
|
|
Invention
|
Gefitnib sensitivity-related gene expression and products and methods related thereto.
Disclosed... |
|
2011
|
Invention
|
Prodrugs of azacitidine 5'-phosphate. The present disclosure relates to analogs or derivatives of... |
|
2009
|
Invention
|
Administration of an inhibitor of hdac, an inhibitor of her-2, and a selective estrogen receptor ... |
|
|
Invention
|
Administration of an inhibitor of hdac and an hmt inhibitor. Methods of treating patients with an... |
|
2008
|
Invention
|
Novel compounds and methods of using them.
Described herein are novel HDAC modulators, formulati... |
|
|
Invention
|
Novel compounds and methods of using them.
Described herein are novel HDAC inhibitors, formulati... |
